H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Census population 204,851. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Port St. Lucie clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Port St. Lucie storefront.
Diabetic Wound Care That Delivers in Port St. Lucie, FL for clinics & physicians. Specialized diabetic wou… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 27.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. diabetic wound care inventory is national; utilization is JN-local.
National Diabetic Wound Care That Delivers notes (how the product actually works)CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Adult obesity in Port St. Lucie is 30.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 27.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JN / First Coast Service Options, sibling states no other states. Florida Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy diabetic wound care elsewhere, use this page as a check: homologous-use language, current First Coast Service Options article IDs, and PLACES 13.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 13.1% of adults — 1.1 points above the U.S. 12% figure. Obesity is 30.5%; arthritis is 27.9%. That is place-level BRFSS modeling, not a clinic census and not a Port St. Lucie trial.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Florida. There is no Port St. Lucie storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers diabetic wound care that delivers and which products they use.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
If you operate in Florida and another MAC state, say it on the first call. JN will not port 1:1. We would rather split utilization than watch a sister clinic copy Port St. Lucie tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Port St. Lucie, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Port St. Lucie is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Port St. Lucie — 1.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Port St. Lucie. Useful for joint-program math; still needs a diagnosis and privileging.
No Port St. Lucie storefront. Joe Bradley is an active practice owner. diabetic wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.